Simultaneous High Performance Liquid Chromatography Assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco™ Lavare Wound Base

Simultaneous High Performance Liquid Chromatography Assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco™ Lavare Wound Base

This article details the elements used in the method verification for the simultaneous high performance liquid chromatography (HPLC) assay of Pentoxifylline, Mupirocin, Itraconazole, and Fluticasone Propionate in Humco™ Lavare Wound base. The method was proven to be linear over 50%–150% of the nomin...

Full description

Bibliographic Details
Main Author:	Troy Purvis
Format:	Article
Language:	English
Published:	MDPI AG 2015-11-01
Series:	Chromatography
Subjects:	Pentoxifylline Mupirocin Itraconazole Fluticasone Propionate high performance liquid chromatography (HPLC) Humco™ Lavare wound base
Online Access:	http://www.mdpi.com/2227-9075/2/4/642

Similar Items

Effects of Salmeterol and Fluticasone Propionate Combination versus Fluticasone Propionate on Airway Function and Eosinophilic Inflammation in Mild Asthma
by: Makoto Hoshino, et al.
Published: (2009-01-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
by: Belchamber KBR, et al.
Published: (2018-09-01)

Fluticasone propionate and increased risk of pneumonia in COPD: is it PAFR-dependent?
by: Sohal SS
Published: (2017-12-01)

The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
by: Xiaofen Jin, et al.
Published: (2020-01-01)

The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis
by: Лариса Михайлівна Станіславчук
Published: (2015-08-01)

Efficacy of fluticasone propionate ointment 0.005% in childhood lichen planus
by: Abhinav Kumar, et al.
Published: (2020-01-01)

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone
by: Raisha G. Dalvi, et al.
Published: (2019-04-01)

Nongenomic Effects of Fluticasone Propionate and Budesonide on Human Airway Anion Secretion
by: Hasegawa, Yoshinori, et al.
Published: (2012)

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy
by: Horiuchi K, et al.
Published: (2016-03-01)

Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)

Comparison of Effectiveness in Ciclesonide and Fluticasone Propionate on Small Airway Function in Mild Asthma
by: Makoto Hoshino
Published: (2010-01-01)

Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017-10-01)

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
by: Philip Lance A. Liu, et al.
Published: (2010-06-01)

Effect of combined application of tiotropium and Salmeterol and fluticasone propionate powder on disease control in stable COPD patients
by: Xiu-Ping Han, et al.
Published: (2016-06-01)

Preparation of nanosized Fluticasone Propionate nasal spray with improved stability and uniformity
by: Dai Jiajia, et al.
Published: (2015-01-01)

The Clinical Evaluation of the Acceptance of Fluticasone Propionate Diskus® by Older Japanese Patients with Bronchial Asthma
by: Hiroyuki Ohbayashi
Published: (2005-01-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
by: Moretz C, et al.
Published: (2020-10-01)

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
by: Marina G. Dogbe, et al.
Published: (2019-10-01)

In vitro aerodynamic analysis of co-spray dried fluticasone propionate (FP) and salmeterol xinafoate (SX) dry powder inhalation aerosols with lactose-alternative excipient
by: Malapit, Monica, et al.
Published: (2017)

Quantitative proton nuclear magnetic resonance method for simultaneous analysis of fluticasone propionate and azelastine hydrochloride in nasal spray formulation
by: Amal A. El-Masry, et al.
Published: (2021-07-01)

Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
by: Bhanu Prakash Kolasani, et al.
Published: (2013-09-01)

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization
by: Nina Maria Ainali, et al.
Published: (2020-08-01)

Hur påverkar restaurering av lövängar naturvårdsintressanta epifytiska lavar?
by: Lundin, Magnus
Published: (2008)

Supercritical CO<sub>2</sub> Extraction of Organic Solvents from Flunisolide and Fluticasone Propionate
by: Lucia Baldino, et al.
Published: (2021-04-01)

Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study
by: Jean Bousquet, et al.
Published: (2017-04-01)

Optimal step-down approach for pediatric asthma controlled by salmeterol/fluticasone: A randomized, controlled trial (OSCAR study)
by: Kenichi Akashi, et al.
Published: (2016-07-01)

Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010-02-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
by: Cheng SL, et al.
Published: (2021-02-01)

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
by: Cheng SL, et al.
Published: (2020-12-01)

Screening for Mupirocin Resistance in Staphylococcus
by: AVR JEYA SANJU, et al.
Published: (2015-10-01)

Preparation of mupirocin-loaded polymeric nanocapsules using essential oil of rosemary
by: Jaqueline Bandeira Rubenick, et al.
Published: (2017-04-01)

IN VITRO ACTIVITY AND EMERGENCE OF RESISTANCE TO MUPIROCIN IN STAPHYLOCOCCUS AUREUS
by: Margalida Rotger, et al.
Published: (2003-10-01)

Incidence of Mupirocin Resistance in Staphylococcus pseudintermedius Isolated from a Healthy Dog
by: Godbeer, Stacey Marie
Published: (2013)

Inventering av mossor och lavar i två olika skogshabitat i Axvall, Västergötland : - håller en blandskog högre artdiversitet än en produktionsskog med gran?
by: Roos, Sara
Published: (2011)

Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+ </sup>regulatory T cells in COPD
by: Yang Li, et al.
Published: (2011-10-01)

Polyaspartamide-Based Nanoparticles Loaded with Fluticasone Propionate and the In Vitro Evaluation towards Cigarette Smoke Effects
by: Emanuela Fabiola Craparo, et al.
Published: (2017-08-01)

The Influence of Essential Oil Compounds on Antibacterial Activity of Mupirocin-Susceptible and Induced Low-Level Mupirocin-Resistant MRSA Strains
by: Paweł Kwiatkowski, et al.
Published: (2019-08-01)

A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US
by: Prenner BM
Published: (2016-07-01)

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
by: Mohammad Aamir Mirza, et al.
Published: (2012-12-01)